Lygature’s Post

We're excited to have Annick de Bruin, Chief Research and Insights Officer, Center for Information and Study on Clinical Research Participation (CISCRP), USA sharing the results from CISCRP's 2023 Perceptions & Insights Study this September at Patient Perspectives and Partnering! This study found that “Information critical to participant decision-making includes knowing potential risks and benefits, study purpose, how the investigational treatment is believed to work, as well as knowing involved procedures, potential out-of-pocket costs, physical clinic location, and study duration”. Join Annick in Amsterdam to learn more about these crucial study findings, as well as experts from Novartis, Regeneron, use MY data, Sanofi, GSK, Boehringer Ingelheim, James Lind Care, FibroFlutters, Genentech, FDA, braintust and many more. And gain leading advice that will help you address these pivotal considerations early, improve patient engagement and maximise your trial outcomes. 📅 Download the agenda to learn more: https://lnkd.in/eJwWvV3N 👉 Register today: https://lnkd.in/eGH7Jqi5 #PatientPerspectives24 #PatientEngagement #ClinicalTrials #ClinicalResearch #PatientPartnerships

A vibrant life sciences hub at the heart of Europe, Belgium boasts a robust environment that fosters the development of multinational drug makers as well as home-grown biotechs and is replete with singular expertise. The EU’s fourth largest pharma R&D spender despite its modest size, Belgium is also a major industry producer and trades over EUR 230 million of biopharmaceuticals every day. Through in-depth interviews with key stakeholders across the Belgian healthcare value chain – including CEOs, government authorities, industry body representatives, heads of the local affiliates of multinational pharma companies, and representatives of Belgian biotech –, this report provides a comprehensive look at Belgium’s healthcare and life sciences ecosystem today. Topics covered include challenges to Belgium’s status as a leading clinical trials hub, ongoing reform of the country’s access and pricing mechanisms, the Belgian biotechs being snapped up by Big Pharma, and lots more. Featuring the insights of: Emmanuelle Boishardy, Pierre BOYER, Frederic Clais, Jasmien Coenen, Isabelle De Walsche, Renaud Decroix, Mark Dekker, Marnix Denys, Pedro Facon, Stefan Gijssels, Johan Heylen, Vanja Hoeben, MMO, Serge Kemps, Diane Kleinermans, Sally Ann McNab, Paul Newton, Ivan Perrichon, Maria Fernanda Prado, Erik Present, Geert Reyniers, Paul Stoffels, MD, Gábor Sztaniszláv, Nicolas van Gelder, An Van Gerven, Luc Van Gorp, Stephan Van Nieuwenhove, Caroline Ven Download Healthcare & Life Sciences Review Belgium 2023 for free at: https://lnkd.in/d-mzXuAv

Join Sidley’s Maarten Meulenbelt, Scott Bass, Marie Manley, and Anne Robert in Brussels on February 7 for our Digital Health App’ero and on February 8 for our annual Life Sciences College. Hosted with EUCOPE - European Confederation of Pharmaceutical Entrepreneurs, this year’s events will feature panel discussions on AI in life sciences, as well as a day of discussion with regulators addressing cutting-edge industry trends and hot topics. Learn more about this year’s speakers and register here today. #lifesciences #digitalhealth #artificialintelligence #pharma

Collaboration is key for pioneering medical advancement It is the collaboration between companies, research and knowledge institutions, and government in Rotterdam that is the breeding ground for many medical innovations that originate here and find their way to patients all over the world. This is also the opinion of Desiree van der Kleij, Chief Operating Officer of Cerba Research. "Ultimately, creating economic value goes hand in hand with improving healthcare and quality of life." @Cerba Research exemplifies this collaborative spirit. By supporting clinical and preclinical studies for the development of drugs and vaccines, they contribute significantly to improving global health. Their advanced diagnostics and expert guidance empower the biopharmaceutical sector to develop next-generation treatments for viral infections. Cerba Research receives these clients in the Rotterdam Science Tower, where it carries out clinical trials for large pharmaceutical companies in a four-story laboratory. A pleasant environment, according to Van der Kleij. "It is a building with a high wow-factor. You walk in and you are not only overwhelmed by the view of the Rotterdam skyline, but we also form an inspiring community that gives ambitious entrepreneurs the place to grow." Learn more about the Rotterdam Science Cluster: https://lnkd.in/ewb7GpUb #Rotterdam #Genomics #LifeSciences #Collaboration #Innovation

⭐ BIO Notebook Day 3: Amgen CEO Blasts IRA, Novo Nordisk Stays Cautious On BD, And More •Who should read this? Pharma and biotech decision-makers – including CEOs, BD&L, strategic intelligence/competitive intelligence, medical, and regulatory/compliance. •What is it? One installment of Scrip’s daily notebook of noteworthy intelligence from the BIO International Convention in San Diego. •Why is it important? BIO is a key industry conference, and Citeline Insights has five reporters covering the event live on the ground. Our writers share key highlights each day, moderate sessions, and write up interviews and features over the coming days. This article highlights Novo Nordisk’s philosophy around spending its GLP-1 windfall on business development. Citeline Citeline Commercial #BIO2024

Andaman7 founder and CEO, Vincent Keunen, has been featured in the Outsourcing-Pharma end-of-year review looking at the biggest challenges and opportunities of 2023 and the predicted trends of 2024. Read the article https://bit.ly/a7op-kpt

📣The Inbeeo view from Swiss Biotech Day!📣 Christel Jansen and Vincenzo Straccia were representing the Inbeeo team at the Swiss Biotech Association Swiss Biotech Day congress recently as well as visiting nearby clients. We were  both amazed to see first-hand such a breadth of innovation coming from this global Life Sciences hub in the heart of Europe – both very exciting and humbling at the same time. Christel and I had the privilege of meeting with organisations at the beginning of their journeys as well as with leaders from global institutions that are improving lives for people around the world at scale. It was a truly inspirational few days! A further highlight was visiting the Roche Building 1 in Basel (thank you again for the snap Christel!😎).  Your team may be at the point of looking for further investor support, or beginning to consider reimbursement strategy or indeed life cycle optimization. Just as with the vision communicated at Swiss Biotech Day and the views from Building 1, Inbeeo can help you see the bigger picture and what is possible. Want to discuss further? Please don't hesitate to reach out! #marketaccess #drugpricing #pharmaceuticals

What were the highlights of the recent clinical trial supply conferences N-SIDE attended?   We haven't finished listing them yet! From reconnecting with familiar industry peers to engaging with new prospects seeking stress-free and sustainable clinical supply planning, our N-SIDE Life Sciences team had a fulfilling experience at conferences across Europe and the US over the past few months!   However, one may particularly stand out: the co-presentation in Barcelona featuring our experts Amaury Jeandrain and Sasha Van Heuverswyn alongside our esteemed partner Sanofi, represented by Arnaud DOURLENS, Head of Clinical Supply Operations. We shared how innovation and data processing combined with a strong culture of performance allowed to double from 35 to 70% the proportion of drug ultimately dispensed to patients and a reduction by up to 50% in the total quantities of drugs required to conduct a trial. This resulted in significant improvements notably in patient service levels, cost savings, and reduced carbon footprint, ultimately enhancing Sanofi's overall performance in clinical trial supply. N-SIDE revolutionizes clinical trials, drastically reducing timelines and enhancing efficiency. Connect with us at our upcoming conferences and discover how we are transforming the industry 👉 https://lnkd.in/e5SgGCFF #LifeSciences #Pharma #Biotech #ClinicalTrials #Conference